• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺腺癌中微血管密度及p53表达的评估

Evaluation of microvessel density and p53 expression in pancreatic adenocarcinoma.

作者信息

Jureidini Ricardo, da Cunha José Eduardo Monteiro, Takeda Flavio, Namur Guilherme Naccache, Ribeiro Thiago Costa, Patzina Rosely, Figueira Estela Rr, Ribeiro Ulysses, Bacchella Telesforo, Cecconello Ivan

机构信息

Faculdade de Medicina da Universidade de São Paulo, Departamento de Gastroenterologia.

Departamento de Patologia, São Paulo/SP, Brazil.

出版信息

Clinics (Sao Paulo). 2016 Jul;71(6):315-9. doi: 10.6061/clinics/2016(06)05.

DOI:10.6061/clinics/2016(06)05
PMID:27438564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4930662/
Abstract

OBJECTIVE

To evaluate the prognostic significance of microvessel density and p53 expression in pancreatic cancer.

METHODS

Between 2008 and 2012, 49 patients with pancreatic adenocarcinoma underwent resection with curative intention. The resected specimens were immunohistochemically stained with anti-p53 and anti-CD34 antibodies. Microvessel density was assessed by counting vessels within ten areas of each tumoral section a highpower microscope.

RESULTS

The microvessel density ranged from 21.2 to 54.2 vessels/mm2. Positive nuclear staining for p53 was found in 20 patients (40.6%). The overall median survival rate after resection was 24.1 months and there were no differences in survival rates related to microvessel density or p53 positivity. Microvessel density was associated with tumor diameter greater than 3.0 cm and with R0 resection failure.

CONCLUSIONS

Microvessel density was associated with R1 resection and with larger tumors. p53 expression was not correlated with intratumoral microvessel density in pancreatic adenocarcinoma.

摘要

目的

评估微血管密度和p53表达在胰腺癌中的预后意义。

方法

2008年至2012年期间,49例胰腺腺癌患者接受了根治性切除手术。切除的标本用抗p53和抗CD34抗体进行免疫组织化学染色。通过在高倍显微镜下对每个肿瘤切片的十个区域内的血管进行计数来评估微血管密度。

结果

微血管密度范围为21.2至54.2个血管/mm²。20例患者(40.6%)发现p53核染色阳性。切除后的总体中位生存率为24.1个月,生存率与微血管密度或p53阳性无关。微血管密度与肿瘤直径大于3.0 cm和R0切除失败有关。

结论

微血管密度与R1切除和较大肿瘤有关。p53表达与胰腺腺癌的肿瘤内微血管密度无关。

相似文献

1
Evaluation of microvessel density and p53 expression in pancreatic adenocarcinoma.胰腺腺癌中微血管密度及p53表达的评估
Clinics (Sao Paulo). 2016 Jul;71(6):315-9. doi: 10.6061/clinics/2016(06)05.
2
Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.基质纤维、微血管密度和免疫细胞群体的排列决定胰腺癌的总生存期-基质形态分析。
PLoS One. 2020 Jul 13;15(7):e0234568. doi: 10.1371/journal.pone.0234568. eCollection 2020.
3
Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.胰腺导管腺癌中的微血管景观评估:以内皮糖蛋白(CD105)作为临床结局预后因素的靶向治疗价值尚不明确。
Pancreas. 2015 Jan;44(1):87-92. doi: 10.1097/MPA.0000000000000197.
4
Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival.胰腺癌中的血管生成:胸苷磷酸化酶在基质细胞中的表达及瘤内微血管密度作为总生存和无复发生存的独立预测指标
Cancer. 2001 Oct 1;92(7):1788-97. doi: 10.1002/1097-0142(20011001)92:7<1788::aid-cncr1695>3.0.co;2-z.
5
VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.血管内皮生长因子和Id-1在胰腺腺癌中的预后意义及对血管生成的影响
Eur J Surg Oncol. 2014 Oct;40(10):1331-7. doi: 10.1016/j.ejso.2014.01.004. Epub 2014 Jan 18.
6
High microvessel density in pancreatic ductal adenocarcinoma is associated with high grade.胰腺导管腺癌中微血管密度高与高级别相关。
Virchows Arch. 2013 May;462(5):541-6. doi: 10.1007/s00428-013-1409-1. Epub 2013 Apr 12.
7
Annexin A2 and CD105 expression in pancreatic ductal adenocarcinoma is associated with tumor recurrence and prognosis.膜联蛋白A2和CD105在胰腺导管腺癌中的表达与肿瘤复发及预后相关。
Asian Pac J Cancer Prev. 2014;15(22):9921-6. doi: 10.7314/apjcp.2014.15.22.9921.
8
Analysis of microvessels in pancreatic cancer: by light microscopy, confocal laser scan microscopy, and electron microscopy.胰腺癌微血管分析:通过光学显微镜、共聚焦激光扫描显微镜和电子显微镜进行分析。
J Hepatobiliary Pancreat Surg. 2008;15(4):384-90. doi: 10.1007/s00534-007-1241-6. Epub 2008 Aug 1.
9
[Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].[壶腹癌和胰腺癌的外科治疗结果及其R0切除术后的预后参数]
Zentralbl Chir. 2005 Aug;130(4):353-61. doi: 10.1055/s-2005-836794.
10
Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients.
Pancreas. 2001 Apr;22(3):240-7. doi: 10.1097/00006676-200104000-00003.

引用本文的文献

1
Preclinical evaluation of a dual-receptor targeted tracer [Ga]Ga-HX01 in 10 different subcutaneous and orthotopic tumor models.在 10 种不同的皮下和原位肿瘤模型中进行双受体靶向示踪剂 [Ga]Ga-HX01 的临床前评估。
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):54-67. doi: 10.1007/s00259-023-06412-z. Epub 2023 Aug 29.
2
Microvessel density in patients with gastrointestinal stromal tumors: A systematic review and meta-analysis.胃肠道间质瘤患者的微血管密度:一项系统评价和荟萃分析。
World J Methodol. 2023 Jun 20;13(3):153-165. doi: 10.5662/wjm.v13.i3.153.
3
Predictive Design and Analysis of Drug Transport by Multiscale Computational Models Under Uncertainty.

本文引用的文献

1
Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells.舒尼替尼显著抑制三阴性乳腺癌的增殖、迁移、抗凋亡、肿瘤血管生成和生长,但会增加乳腺癌干细胞。
Vasc Cell. 2014 Jun 1;6:12. doi: 10.1186/2045-824X-6-12. eCollection 2014.
2
Enhancement of nab-paclitaxel antitumor activity through addition of multitargeting antiangiogenic agents in experimental pancreatic cancer.通过添加多种靶向抗血管生成药物增强实验性胰腺癌中nab-紫杉醇的抗肿瘤活性。
Mol Cancer Ther. 2014 May;13(5):1032-43. doi: 10.1158/1535-7163.MCT-13-0361. Epub 2014 Mar 7.
3
多尺度计算模型在不确定性下的药物传输预测设计与分析。
Pharm Res. 2023 Feb;40(2):501-523. doi: 10.1007/s11095-022-03298-8. Epub 2022 Jun 1.
4
Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer.胰腺癌经典及新型生物标志物的临床应用
Cancers (Basel). 2022 Apr 7;14(8):1866. doi: 10.3390/cancers14081866.
Stromal expression of SPARC in pancreatic adenocarcinoma.
胰腺癌中SPARC的基质表达。
Cancer Metastasis Rev. 2013 Dec;32(3-4):585-602. doi: 10.1007/s10555-013-9439-3.
4
Screening for early pancreatic ductal adenocarcinoma: an urgent call!早期胰腺导管腺癌的筛查:紧急呼吁!
JOP. 2009 Mar 9;10(2):104-8.
5
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?胰腺癌胰十二指肠切除术后的长期生存:能否治愈?
Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.
6
Cancer statistics, 2007.2007年癌症统计数据。
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
7
Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.中国地理区域局限性食管鳞状细胞癌组中p53的突变谱。
Cancer. 2004 Aug 15;101(4):834-44. doi: 10.1002/cncr.20437.
8
p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.成人星形细胞瘤和少突胶质细胞瘤中的p53蛋白改变。
Neurol India. 2004 Jun;52(2):228-32.
9
Evaluation of angiogenesis, p-53 tissue protein expression and serum VEGF in patients with endometrial cancer.子宫内膜癌患者血管生成、p-53组织蛋白表达及血清血管内皮生长因子的评估
Neoplasma. 2004;51(3):193-7.
10
Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach.血管内皮生长因子在胃胃肠道间质瘤中的表达及血管生成
Oncology. 2003;64(3):266-74. doi: 10.1159/000069316.